SE0200974D0 - Screening method for gastritis - Google Patents

Screening method for gastritis

Info

Publication number
SE0200974D0
SE0200974D0 SE0200974A SE0200974A SE0200974D0 SE 0200974 D0 SE0200974 D0 SE 0200974D0 SE 0200974 A SE0200974 A SE 0200974A SE 0200974 A SE0200974 A SE 0200974A SE 0200974 D0 SE0200974 D0 SE 0200974D0
Authority
SE
Sweden
Prior art keywords
antibodies
gastritis
pepsinogen
concentration
atpase
Prior art date
Application number
SE0200974A
Other languages
English (en)
Inventor
Sven Maardh
Original Assignee
Phagen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phagen Ab filed Critical Phagen Ab
Priority to SE0200974A priority Critical patent/SE0200974D0/sv
Publication of SE0200974D0 publication Critical patent/SE0200974D0/sv
Priority to AT03745056T priority patent/ATE449338T1/de
Priority to JP2003578931A priority patent/JP2005521055A/ja
Priority to PCT/SE2003/000469 priority patent/WO2003081248A1/en
Priority to CA002478891A priority patent/CA2478891A1/en
Priority to AU2003216007A priority patent/AU2003216007A1/en
Priority to CN03806799.4A priority patent/CN1701235A/zh
Priority to EP03745056A priority patent/EP1488238B1/en
Priority to DE60330125T priority patent/DE60330125D1/de
Priority to NZ535937A priority patent/NZ535937A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/062—Gastritis or peptic ulcer disease
SE0200974A 2002-03-27 2002-03-27 Screening method for gastritis SE0200974D0 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE0200974A SE0200974D0 (sv) 2002-03-27 2002-03-27 Screening method for gastritis
AT03745056T ATE449338T1 (de) 2002-03-27 2003-03-21 Screening-verfahren für gastritis
JP2003578931A JP2005521055A (ja) 2002-03-27 2003-03-21 胃炎のスクリーニング法
PCT/SE2003/000469 WO2003081248A1 (en) 2002-03-27 2003-03-21 Screening method for gastritis
CA002478891A CA2478891A1 (en) 2002-03-27 2003-03-21 Screening method for gastritis
AU2003216007A AU2003216007A1 (en) 2002-03-27 2003-03-21 Screening method for gastritis
CN03806799.4A CN1701235A (zh) 2002-03-27 2003-03-21 胃炎筛选方法
EP03745056A EP1488238B1 (en) 2002-03-27 2003-03-21 Screening method for gastritis
DE60330125T DE60330125D1 (de) 2002-03-27 2003-03-21 Screening-verfahren für gastritis
NZ535937A NZ535937A (en) 2002-03-27 2003-03-21 Assaying for H,K-ATPase antibodies, H. pylori antibodies and pepsinogen I concentration for diagnosing the presence of possible gastritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0200974A SE0200974D0 (sv) 2002-03-27 2002-03-27 Screening method for gastritis

Publications (1)

Publication Number Publication Date
SE0200974D0 true SE0200974D0 (sv) 2002-03-27

Family

ID=20287443

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0200974A SE0200974D0 (sv) 2002-03-27 2002-03-27 Screening method for gastritis

Country Status (10)

Country Link
EP (1) EP1488238B1 (sv)
JP (1) JP2005521055A (sv)
CN (1) CN1701235A (sv)
AT (1) ATE449338T1 (sv)
AU (1) AU2003216007A1 (sv)
CA (1) CA2478891A1 (sv)
DE (1) DE60330125D1 (sv)
NZ (1) NZ535937A (sv)
SE (1) SE0200974D0 (sv)
WO (1) WO2003081248A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI119572B (sv) * 2004-03-05 2008-12-31 Biohit Oyj Förfarande för att förutspå tillståndet hos magslemhinnan
EP2203745A4 (en) * 2007-10-26 2010-12-08 Biohit Oyj METHODS AND PRODUCTS FOR DIAGNOSING AUTOIMMUNE DISEASES AND GASTRIC CANCER RELATED TO ATROPHIC GASTRITIS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4139840B4 (de) 1990-12-04 2005-06-02 Quidel Corp., San Diego Antigen-Zubereitung zum Nachweis von H. pylori
IT1262895B (it) 1992-03-02 1996-07-22 Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.
CA2067603A1 (en) 1992-04-29 1993-10-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva
US5524622A (en) 1994-09-20 1996-06-11 Oregon Health Sciences University Non-invasive method of determining inflammation of the gastrointestinal tract
US5879897A (en) 1996-09-23 1999-03-09 Wake Forest University Methods and compositions for the diagnosis of extraesophageal gastric reflux
US6067989A (en) 1997-02-26 2000-05-30 Oridion Medical, Ltd. Breath test for the diagnosis of Helicobacter pylori infection in the gastrointestinal tract
FI118653B (sv) * 1999-04-30 2008-01-31 Biohit Oyj Förfarande för att bestämma risken för peptiskt sår

Also Published As

Publication number Publication date
EP1488238B1 (en) 2009-11-18
NZ535937A (en) 2006-08-31
JP2005521055A (ja) 2005-07-14
DE60330125D1 (de) 2009-12-31
ATE449338T1 (de) 2009-12-15
AU2003216007A1 (en) 2003-10-08
WO2003081248A1 (en) 2003-10-02
CN1701235A (zh) 2005-11-23
EP1488238A1 (en) 2004-12-22
CA2478891A1 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
DK1141728T3 (da) Påvisning af nyresygdom og behandling deraf
ATE312946T1 (de) Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten
DE60228557D1 (de) Candida-nachweis
MY133942A (en) Reagent test strip for analyte determination having hemolyzing agent
ATE245937T1 (de) Überwachung physiologischer analyte
DE69910007D1 (de) Vorrichtung zum vorhersagen von physiologischen messwerten
DE60314042D1 (de) Vorrichtungen und Methoden zur Bestimmung von Konzentrationen von Analyten
ATE332667T1 (de) Verfahren und vorrichtung zur sammlung von physiologischen proben
DE60317422D1 (de) Mediator-stabilisierende Verbindung und Methoden zur Verwendung zur Detektion elektrochemischer Analyte
WO2001011354A3 (en) Methods for characterizing, classifying, and identifying unknowns in samples
CY1107859T1 (el) Μεθοδος για διαγνωση πολλαπλης σκληρυνσης
ATE385574T1 (de) Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen
WO2004011607A3 (en) Reagent and method for determination of a substance using an immunoaggregator
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
WO2004057341A3 (en) Cvd assay
SE0200974D0 (sv) Screening method for gastritis
EP1159614A4 (en) DIAGNOSTIC METHOD FOR ASTHMA
ATE420364T1 (de) Verfahren zur magenkrebsvorhersage
DK1095271T3 (da) Fremgangsmåde til diagnose af hjertekar-sygdomme og tidlig aterosklerose
EA200500449A1 (ru) Способ выявления риска развития у субъекта заболевания, связанного с кислотой
NO20034059D0 (no) Fremgangsmåte for screening av pre-diabetiske tilstander og screening-reagens
ATE421093T1 (de) Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten
WO2006026808A8 (en) Method of diagnosing and/or predicting the development of an allergic disorder
WO2003027656A3 (en) Electrochemical control of the redox environment for the analysis of a sample
DE59910326D1 (de) Verwendung derivatisierter Reagenzien in Chemilumineszenz- und Elektrochemilumineszenz-Nachweisverfahren